BackYield10 Bioscience Overview

Yield10 Bioscience Long Term Debt

Track Yield10 Bioscience's long-term debt ($1.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$1.09M
61.36% YoYΔ $-1.73M vs prior year quarter

Peer trimmed avg / median

Loading

Yield10 Bioscience Long Term Debt History

Loading

Yield10 Bioscience vs. peers: Long Term Debt Comparison

Loading

Yield10 Bioscience Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Yield10 Bioscience (YTEN) FAQ

As of the most recent data (June 2024), YTEN shows a long-term debt of $1.1M. That compares with $2.8M in the prior-year period — down 61.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YTEN's long-term debt is now $1.1M (was $2.8M) — a 61.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Yield10 Bioscience is outperforming or lagging.

Tracking YTEN's long-term debt over time shows whether Yield10 Bioscience is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $2.8M in the prior-year period — down 61.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Yield10 Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $1.1M) with ownership activity and broader fundamentals.

Yield10 Bioscience's long-term debt is $1.1M; compare it with other Consumer Discretionary names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.